Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Headache
JNNP 57:134-143, Pearce,J.M.S., 1994
Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019
Preventive Migraine Drug Approved
JAMA 320:1746, , 2018
Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018
Migraine
NEJM 377:553-561, Charles, A., 2017
CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017
Chronic Migraine Headache Prevention with Noninvasive Vagus Nerve Stimulation
Neurol 87:529-538, Silberstein, S.D.,et al, 2016
Chronic Migraine
BMJ 348:g141b, Schwedt, T.J., 2014
Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults
JAMA 307:1736-1745, Jackson,J.L.,et al, 2012
OnabotulinumtoxinA Improves Quality of Life and Reduces Impact of Chronic Migraine
Neurol 77:1465-1472, Lipton, R.B.,et al, 2011
Recent Advances in the Diagnosis and Management of Migraine
BMJ 332:25-29, Goadsby,P.J., 2006
Migraine
Lancet 363:381-391, Silberstein,S.D., 2004
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Headache
BMJ 325:881-886, Steiner,T.J. &Fontebasso,M., 2002
Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
Ann Int Med 137:840-849, Snow,V.,et al, 2002
Central Anticholinergic Syndrome on Therapeutic Doses of Cyproheptadine
Pediatrics 103:158-160, Watemberg,N.M.,et al, 1999
A 27-Year-Old Woman with Migraine Headaches
JAMA 278:322-328, Welch,K.M.A., 1997
Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996